M 8960 5 mg Pill - white capsule/oblong, 14mm
Pill with imprint M 8960 5 mg is White, Capsule/Oblong and has been identified as Dextroamphetamine Sulfate Extended Release 5 mg. It is supplied by Mallinckrodt Pharmaceuticals.
Dextroamphetamine is used in the treatment of ADHD; Narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dextroamphetamine 5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for M 8960 5 mg
Dextroamphetamine Sulfate Extended Release
- Imprint
- M 8960 5 mg
- Strength
- 5 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Mallinckrodt Pharmaceuticals
- National Drug Code (NDC)
- 00406-8960
- Inactive Ingredients
-
sucrose,
corn starch,
titanium dioxide,
ferrosoferric oxide,
propylene glycol,
FD&C Red No. 40,
FD&C Blue No. 1,
aluminum oxide,
alcohol,
isopropyl alcohol,
butyl alcohol,
ammonia,
FD&C Blue No. 2,
hypromellose 2208 (100000 mPa.s),
water,
medium-chain triglycerides,
oleic acid
Note: Inactive ingredients may vary.
Related images for "M 8960 5 mg"
More about dextroamphetamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (294)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
- Dextroamphetamine drug information
- Dextroamphetamine Tablets
- Dextroamphetamine Sustained-Release Capsules
- Dextroamphetamine Oral Solution
Other brands
Dexedrine, Zenzedi, Dextrostat, ProCentra, ... +2 more
Professional resources
- Dextroamphetamine monograph
- Dextroamphetamine (FDA)
- Dextroamphetamine ER (FDA)
- Dextroamphetamine Extended-Release Capsules (FDA)
- Dextroamphetamine Oral Solution (FDA)
Other brands
Dexedrine, Zenzedi, Dextrostat, ProCentra, Xelstrym
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.